Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06168825 · ClinicalTrials.gov registry record

Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention

A clinical trial, sponsored by Inova Health Care Services.

Completed
Registry status
40
Enrollment target

NCT06168825 is a clinical trial that has completed, run by Inova Health Care Services. The registered enrollment target is 40 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06168825 has completed, sponsored by Inova Health Care Services.

COMPLETED
Registry status
40 participants
Enrollment target

Study Summary

The goal of this study is to learn if the Mind Over Matter (MOM) Intervention, a 5-week group program, can help Black and African American women deal with the fears, worries and sadness that often accompany cancer diagnosis and treatment. The main question this study aims to answer is: • Whether the MOM Intervention is feasible and acceptable among Black and African American women. We would also like to find out if: * The MOM Intervention decreases anxiety, depression and physical symptom severity for Black and African American women. * The MOM Intervention is culturally and linguistically appropriate, and identify barriers, strengths, and areas of improvement. Participants will: * Attend a Pre-Program Orientation * Attend 5 weekly MOM Sessions * Complete 2 questionnaires (one will be given before the first MOM Session begins, and the other will be given after the last MOM Session) Participants also have the choice to attend an optional Focus Group, which will be offered after the last MOM Session. Please note, this entire Intervention will be offered online. There will be no in-person sessions or visits.

Interventions

  • OTHER Mind Over Matter (MOM)

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-01-17
Est. Completion 2024-06-04

Sponsor

Inova Health Care Services

75 total trials

What the Registry Record Tells You About NCT06168825

The ClinicalTrials.gov registry entry for NCT06168825 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Inova Health Care Services, which has 75 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Mind Over Matter (MOM) is the first listed.

NCT06168825 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06168825 about?

NCT06168825 is a clinical study titled "Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention". The goal of this study is to learn if the Mind Over Matter (MOM) Intervention, a 5-week group program, can help Black and African American women deal with the fears, worries and sadness that often accompany cancer diagnosis and treatment. The main question this study aims to answer is: • Whether th...

What is the current status of trial NCT06168825?

This trial is currently completed. The enrollment target is 40 participants. The study started on 2024-01-17. Estimated completion is 2024-06-04.

What interventions are being tested in trial NCT06168825?

The interventions under investigation include: Mind Over Matter (MOM) (OTHER).

Who is sponsoring clinical trial NCT06168825?

This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.